Vieworks Wins FDA Approval for Its Newest VIVIX-S F series


    ANYANG, South Korea, Aug. 5, 2022 /PRNewswire/ — Vieworks, a leading digital X-ray imaging solution provider based in South Korea, noted that its newest VIVIX-S F series has been authorized by the US Food and Drug Administration (FDA) last July. Regulatory clearance from the FDA will allow Vieworks to commercialize its new VIVIX-S F series, which is Vieworks’ premium static X-ray DR flat panel detectors equipped with advanced technology and cutting-edge hardware design. The cassette-sized DR detectors are offered in 3 sizes – 25x30cm (VIVIX-S 2530FW), 36x43cm (VIVIX-S 3643FW), and 43x43cm (VIVIX-S 4343FW).

    VIVIX-S F series
    VIVIX-S F series

    1. FINEST Image Quality

    • High resolution images with 99µm pixel pitch
    • Semi-dynamic feature (multi-frame mode)
    • Anatomy-based image enhancement with photon-understanding AI solution
    • Advanced image processing technology (VXvue, Software-based Scatter Correction)

    2. FINEST Durability

    • Unbreakable glass-free TFT (flexible TFT)
    • Excellent durability (1.5m drop tested, 400kg load limit)
    • IP67 water and dust resistance
    • Wider operating temperature

    3. FINEST Usability

    • Lighter weight for greater portability
    • Convenient charging (wireless charging, separate battery charger, USB-C type, magnetic tether, cradle)
    • Long lasting battery life (16 hours with two batteries, hot-swap mode)
    • Easy usage with user-friendly functions (Fast and convenient detector sharing by NFC, OLED status screen)

    Source: Vieworks Co., Ltd.